Alopecia Areata After Mogamulizumab Treatment

    November 2021 in “ JAAD Case Reports ”
    Neel S. Raval, Nora A. Alexander, Karlee De Monnin … Amy Musiek
    Studysummary This study highlights that although mogamulizumab is highly effective for treating mycosis fungoides and Sézary syndrome, it frequently causes a variety of rashes as side effects.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on secure.jbs.elsevierhealth.com →
    Discuss this study in the Community →

    Research cited in this study 2

    1. Nivolumab-Induced Alopecia Areata: A Case Report and Literature Review Annals of dermatology/Annals of Dermatology · 2021
    2. Alopecia Areata Patients Show Deficiency of FOXP3+CD39+ T Regulatory Cells and Clonotypic Restriction of Treg TCRβ-Chain, Highlighting the Immunopathological Aspect of the Disease PloS one · 2019

    Related research 1

    1. Twenty Nail Dystrophy with Alopecia Areata in an Atopic Child International journal of research in dermatology · 2019